These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7831667)

  • 1. Association of increased fibrin turnover and defective fibrinolytic capacity with leg atherosclerosis. The PLAT Group.
    Cortellaro M; Cofrancesco E; Boschetti C; Mussoni L; Donati MB; Catalano M; Gabrielli L; Lombardi B; Specchia G; Tavazzi L
    Thromb Haemost; 1994 Aug; 72(2):292-6. PubMed ID: 7831667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
    Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.
    Pradhan AD; LaCroix AZ; Langer RD; Trevisan M; Lewis CE; Hsia JA; Oberman A; Kotchen JM; Ridker PM
    Circulation; 2004 Jul; 110(3):292-300. PubMed ID: 15238458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain.
    Heinrich J; Schulte H; Schönfeld R; Köhler E; Assmann G
    Thromb Haemost; 1995 Mar; 73(3):374-9. PubMed ID: 7667818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation.
    Pärsson H; Holmberg A; Siegbahn A; Bergqvist D
    Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):186-92. PubMed ID: 14718902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.
    Cortellaro M; Cofrancesco E; Boschetti C; Mussoni L; Donati MB; Cardillo M; Catalano M; Gabrielli L; Lombardi B; Specchia G
    Arterioscler Thromb; 1993 Oct; 13(10):1412-7. PubMed ID: 8399077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies--a crucial role for acquired free protein S deficiency.
    Ames PR; Tommasino C; Iannaccone L; Brillante M; Cimino R; Brancaccio V
    Thromb Haemost; 1996 Aug; 76(2):190-4. PubMed ID: 8865529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of lipoprotein(a) with atherothrombotic events and fibrinolytic variables. A case-control study.
    Franceschini G; Cofrancesco E; Safa O; Boschetti C; Tremoli E; Mussoni L; Sirtori CR; Cortellaro M
    Thromb Res; 1995 May; 78(3):227-38. PubMed ID: 7631303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators.
    Shahar E; Folsom AR; Salomaa VV; Stinson VL; McGovern PG; Shimakawa T; Chambless LE; Wu KK
    Circulation; 1996 Jun; 93(11):1970-5. PubMed ID: 8640970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated plasma fibrinogen and increased fibrin turnover among healthy women who both smoke and use low-dose oral contraceptives--a preliminary report.
    Scarabin PY; Vissac AM; Kirzin JM; Bourgeat P; Amiral J; Agher R; Guize L
    Thromb Haemost; 1999 Sep; 82(3):1112-6. PubMed ID: 10494773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease.
    van der Bom JG; Bots ML; Haverkate F; Meijer P; Hofman A; Kluft C; Grobbee DE
    Thromb Haemost; 2001 Feb; 85(2):234-9. PubMed ID: 11246539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study.
    Tzoulaki I; Murray GD; Price JF; Smith FB; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Am J Epidemiol; 2006 Feb; 163(4):334-41. PubMed ID: 16357107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of the fibrinolytic system in patients with peripheral arterial occlusive disease.
    Poredos P; Stegnar M; Gacnik A
    Vasa; 1999 May; 28(2):106-11. PubMed ID: 10409921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy.
    Sartori MT; Rigotti P; Marchini F; Spiezia L; Baldan N; Furian L; Varvarikis C; Girolami A
    Transplantation; 2003 Apr; 75(7):994-8. PubMed ID: 12698086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercoagulable state indicates an additional risk factor for atherosclerosis in Werner's syndrome.
    Goto M; Kato Y
    Thromb Haemost; 1995 Apr; 73(4):576-8. PubMed ID: 7495061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial troponin T release is associated with enhanced fibrinolysis in patients with acute coronary syndromes.
    Ehlers R; Büttcher E; Kazmaier S; Beyer ME; Helber U; Szabo S; Wendel HP; Hoffmeister HM
    Thromb Haemost; 2001 Nov; 86(5):1176-80. PubMed ID: 11816703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma D-dimer concentration in patients with systemic sclerosis.
    Marie I; Borg JY; Hellot MF; Levesque H
    Br J Dermatol; 2008 Feb; 158(2):392-5. PubMed ID: 18028493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.